Clean Science and Technology Q2FY26 Results: Profit at ₹55 Cr; Margins Stable Despite Revenue Dip

Pune, November 6, 2025: Specialty chemicals manufacturer Clean Science and Technology Ltd (NSE: CLEAN, BSE: 543318) reported consolidated revenue of ₹245 crore for the quarter ended September 30, 2025 (Q2FY26), up 3% year-on-year (YoY), though sequentially flat. The company’s profit after tax (PAT) came in at ₹55 crore, down 6% YoY and 21% QoQ, impacted by higher raw material expenses and moderate volume growth.

Clean Science and Technology Ltd is among the world’s largest producers of performance and specialty chemicals. This includes MEHQ, BHA, Guaiacol, and HALS series. It caters to clients across pharmaceuticals, agrochemicals, polymers, and FMCG sectors. Its exports contribute over 60% of the revenue. The company was founded in 2003 and is listed on NSE and BSE. It trades under the tickers respectively CLEAN and 543318 is part of the Nifty Smallcap 250 index.

Key Financial Highlights (₹ crore)

The company generated ₹245 crore in revenue from operations during the quarter. This marked a 3% YoY increase from ₹238 crore. This also marks a 1% QoQ increase from ₹243 crore. The EBITDA, however, fell to ₹87 crore, a 3% YoY decline and a 13% QoQ decline. Even the EBITDA margin decreased to 36.4% from 38.2% in Q2FY25. The losses extended to PBT and PAT as both also fell. PBT reached ₹75 crore, a 10% YoY decline. And the PAT reached ₹55 crore, a 6% YoY decline.

The quarter end also marked the end of the first half of the financial year. During H1FY26, the company’s consolidated revenue reached ₹488 crore, a 6% YoY increase. while PAT was ₹125 crore, maintaining last year’s level. EBITDA margin for the half-year stood at 38.9% versus 40.4% in H1FY25.

Business & Segmental Highlights

The various segments had similar financial results individually. The performance chemicals segment contributed 75% of total revenue in H1FY26. This was led by strong demand in the HALS (Hindered Amine Light Stabilizers) series. Whereas the Pharma and Agro Intermediates segment formed 16%. It was followed by FMCG chemicals, which were 9% of total revenue. The export share remained robust at 63%. It spanned 35+ countries across Europe, the Americas, China, and India. The company continues to operate with zero debt. It has a healthy consolidated cash position of ₹9 crore as of September 30, 2025.

Management & Governance

The company is led by technocrat promoters Ashok Boob (MD) and Siddharth Sikchi (ED). The focus on R&D-driven growth. It operates four independent R&D labs with 90 scientists and 15+ core chemistries. The Board includes industry veterans such as Pradeep Rathi, Prof. G. D. Yadav, and Madhu Dubhashi. This underscores strong governance standards.

Sustainability & ESG Focus

Clean Science integrates ESG principles through measurable targets. It has 65% renewable energy share. It also plans to install 20 MW of solar capacity. The company aims to cut GHG emissions, water use, and energy consumption by 15% over five years. It has so far invested ₹18 crore in CSR over the past three years. Its CSR activities focus on healthcare, education, and sustainability initiatives.

Market Snapshot

The shares of Clean Science and Technology Limited closed at ₹983.80 on November 06, 2025. This is a 0.01% or ₹0.10 decrease from its previous close of ₹983.90. The intraday range was between ₹960.00 and ₹992.20. The company has had a decent trading session. Its total market capitalisation stood at ₹10,455.22 crore. Further, it had total traded value and volume of ₹67.58 crore and 6.92 lakh shares, respectively.

REF: https://nsearchives.nseindia.com/corporate/CLEAN_06112025134404_Investor_Presentation_06112025.pdf

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations